51 results
Posted on 25.02.2021
The impact of the pandemic on people living with rare diseases
Almost 12 months after the WHO declared a global COVID-19 pandemic, people with rare diseases can reflect on a turbulent year – even if there are some positive lessons to be learned in how services are delivered. While the pandemic continues, most reflections on the crisis come to a common conclusion: everyone suffered, but not […]
Posted on 02.02.2021
Biobanks and medtech: an underdeveloped partnership
Unlocking academia-industry collaboration on sample collection, storage and sharing COVID-19 has demonstrated that access to quality samples and clinical data is key to facing any healthcare challenge. Millions of people have been tested around the world, generating an enormous number of samples and patients’ data. Of course, swabs can have a life after the results […]
Posted on 28.01.2021
Answering the Call of Telehealth
Even before the COVID-19 pandemic, video consultations were on the rise, with many healthcare systems advocating a digital-first approach. In patient care and clinical trials, demand for virtual care has never been higher. The pandemic has accelerated this shift. For me, it has been exciting to collaborate with health systems at a time of urgent […]
Posted on 26.11.2020
In vitro diagnostics at risk: Covid-19 delays progresses towards the new European regulations
In order to keep them available to the health care system and to patients, more than 85% of IVDs will need to be updated in view of the new in vitro Diagnostic Regulation (IVDR) which is at risk due to the ongoing COVID-19 pandemic. The remaining IVDR transition time is not sustainable and requires attention […]
Posted on 30.10.2020
Planning ahead – with clear data
With more than 45 million confirmed cases and more than 1 million deaths at the time of writing, the coronavirus pandemic has wreaked havoc in virtually all countries around the world. Beyond grinding day-to-day life to a halt, the ongoing situation has prompted a reckoning throughout the health care industry, which is facing unprecedented challenges […]
Posted on 26.10.2020
COPD & COVID-19: Pandemic must prompt shift to connected care
For people living with chronic obstructive pulmonary disease (COPD), a long-term lung illness, COVID-19 is having a major impact. The pandemic has disrupted traditional models of care and put vulnerable patients at risk. Keeping patients out of hospital – by reducing scheduled visits and avoiding emergency admissions – has become the top priority. A silver […]
Posted on 20.10.2020
In crisis, medtech found the path to realise its full potential
I have been truly humbled by the collective response of the medical technology industry through this pandemic. As we approach MedTech Week 2020, our industry can be proud of the contribution we have made. But as we reflect on the impact of this unprecedented year, perhaps the true legacy has yet to reveal itself: how […]
Posted on 29.09.2020
Your heart has never been more important
The unprecedented COVID-19 has fundamentally shifted society’s and government’s attention and prioritisation of healthcare. Never has health topped our agenda as much as today – as an individual trying to stay healthy, as healthcare professional and facility trying to deliver a high quality of care, as industry trying to deliver the best innovations to improve […]
Posted on 21.09.2020
EU Health PPP: a new era for medtech companies
For decades, companies in the medtech and pharma sectors have delivered healthcare innovations separately – collaboration has been limited. However, we know that this is not how patients experience healthcare. In the real world, diagnostics, devices, medicines, vaccines and digital tools combine to keep people healthy and to treat those who are unwell. This reality […]